Gilson Connect
Get fast, high-yield, and high-purity isolations without the need for long washing steps. This is possible thanks to our exclusive Exclusion-based Sample Preparation (ESP™) technology. It is perfect for capturing weakly bound protein complexes without subjecting them to high shear forces from pipette-based wash steps. Plus, it prevents contamination, dilution, or discarding of the original samples.
Gilson and Funai show a preview of the soon-to-be-released Gilson Digital Dispenser. This is a non-contact dispenser capable of dispensing DMSO and aqueous solutions from pL to µL. The large dynamic range makes it ideal for dose-response studies, serial dilutions, and assay miniaturization. In this webinar, our attending experts demonstrate the functionality of the new Digital Dispenser with a cell-based assay example.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease caused by the death of motor neurons. A hallmark of ALS is low expression of neurofilament light chain (NFL) in motor neurons. A high-throughput phenotypic assay using patient-derived induced pluripotent stem cells (iPSCs) was used to screen over 6,000 compounds. This poster demonstrates how automation of serial dilutions and dosing on PIPETMAX 268 provides a more accurate and less labor-intensive alternative to manual pipetting for rescreening.
The Gilson Safe Aspiration Station is a stand-alone motorized vacuum system for quick and easy aspiration of biological liquid waste disposal. Liquids are quickly and safely aspirated and collected in a 4 L polypropylene bottle. The station offers adjustable aspiration speed and handles, ideal for ELISA tests, cell culture, and any other contaminated or hazardous liquid aspiration and disposal.
In this app note, PIPETMAX 268, an automated pipetting platform for maximizing reproducibility of biological sample preparation, was used to demonstrate the reproducibility and accuracy for a cell-based mechanistic toxicity profiling application.
We interviewed Dr. Francesco Fiorentino, Founder and CSO of Kitos Biotech, to discuss his lab and its transition to automated liquid handling. Learn more about their story and how they have gained a competitive advantage in the market of preclinical research.
